Standout Papers

Reactive oxygen species-powered cancer immunotherapy: Current status and challenges 2023 2026 202498
  1. Reactive oxygen species-powered cancer immunotherapy: Current status and challenges (2023)
    Mengying He, Tao Xu et al. Journal of Controlled Release

Immediate Impact

8 from Science/Nature 66 standout
Sub-graph 1 of 21

Citing Papers

Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice
2024 Standout
Legume rhizodeposition promotes nitrogen fixation by soil microbiota under crop diversification
2024 Standout
3 intermediate papers

Works of Mengying He being referenced

Ranolazine prevents pressure overload‐induced cardiac hypertrophy and heart failure by restoring aberrant Na+ and Ca2+ handling
2018
Structure–Activity Relationship of Flavonoids on Their Anti-Escherichia coli Activity and Inhibition of DNA Gyrase
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
Mengying He 434 157 29 268 233 41 1.4k
Hua Zhang 416 115 5 213 112 50 1.3k
Santanu Biswas 361 78 5 340 90 37 1.4k
Min Yang 698 37 8 227 144 62 1.5k
Shu‐Chen Hsieh 722 36 4 255 148 70 1.9k
Youngae Jung 771 60 6 147 93 52 1.5k
Bernard M. Wagner 434 293 6 323 96 70 2.2k
Ulrich Mayr 484 60 4 316 71 73 1.4k
Peipei Yin 550 144 2 203 71 52 1.5k
Qinchang Zhu 489 49 290 106 51 1.3k
Jun‐Hui Choi 664 42 1 310 89 70 1.6k

All Works

Loading papers...

Rankless by CCL
2026